Physician profile
Kaley Mcnabb
NPI 1518453331
$2,110.88
in general payments reported to CMS, 2019-2025
7 companies · $23.09 in 2025
The $23.09 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $85.67 · 2023: $54.13 · 2024: $1,740 · 2025: $23.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $808 · Consulting Fee: $700 · Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $808.07 |
| Consulting Fee | $700.00 |
| Food and Beverage | $309.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $1,736.71 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $241.56 | 2021-2023 | Xiaflex |
| Stryker Corporation | $62.32 | 2021-2024 | Aequalis Perform Reversed, Aequalis Perform |
| Mvp Orthopedics INC | $27.36 | 2022 | |
| Bioventus LLC | $19.02 | 2021 | |
| Smith+Nephew, INC. | $12.81 | 2022 | |
| Daxor Corporation | $11.10 | 2023 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaley Mcnabb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.